BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 1935936)

  • 1. Affinity labeling of pig kidney 3,4-dihydroxyphenylalanine (Dopa) decarboxylase with N-(bromoacetyl)pyridoxamine 5'-phosphate. Modification of an active-site cysteine.
    Dominici P; Maras B; Mei G; Borri Voltattorni C
    Eur J Biochem; 1991 Oct; 201(2):393-7. PubMed ID: 1935936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pig kidney dopa decarboxylase: inactivation by iodoacetamide and sequence of the carboxyamidomethylcysteine-containing peptide.
    Dominici P; Simmaco M; Tancini B; Barra D; Borri Voltattorni C
    J Enzyme Inhib; 1989; 3(1):67-76. PubMed ID: 2487323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific labeling of the essential cysteine residue of L-methionine gamma-lyase with a cofactor analogue, N-(bromoacetyl)pyridoxamine phosphate.
    Nakayama T; Esaki N; Tanaka H; Soda K
    Biochemistry; 1988 Mar; 27(5):1587-91. PubMed ID: 3365412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Limited tryptic proteolysis of pig kidney 3,4-dihydroxyphenylalanine decarboxylase.
    Tancini B; Dominici P; Simmaco M; SchininĂ  ME; Barra D; Voltattorni CB
    Arch Biochem Biophys; 1988 Feb; 260(2):569-76. PubMed ID: 3124758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An essential arginine residue at the binding site of pig kidney 3,4-dihydroxyphenylalanine decarboxylase.
    Tancini B; Dominici P; Barra D; Voltattorni CB
    Arch Biochem Biophys; 1985 May; 238(2):565-73. PubMed ID: 3994391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemical modification of pig kidney 3,4-dihydroxyphenylalanine decarboxylase with diethyl pyrocarbonate. Evidence for an essential histidyl residue.
    Dominici P; Tancini B; Borri Voltattorni C
    J Biol Chem; 1985 Sep; 260(19):10583-9. PubMed ID: 4030758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reaction of dopa decarboxylase with alpha-methyldopa leads to an oxidative deamination producing 3,4-dihydroxyphenylacetone, an active site directed affinity label.
    Bertoldi M; Dominici P; Moore PS; Maras B; Voltattorni CB
    Biochemistry; 1998 May; 37(18):6552-61. PubMed ID: 9572873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pig kidney 3,4-dihydroxyphenylalanine (dopa) decarboxylase. Primary structure and relationships to other amino acid decarboxylases.
    Maras B; Dominici P; Barra D; Bossa F; Voltattorni CB
    Eur J Biochem; 1991 Oct; 201(2):385-91. PubMed ID: 1935935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutation of cysteine 111 in Dopa decarboxylase leads to active site perturbation.
    Dominici P; Moore PS; Castellani S; Bertoldi M; Voltattorni CB
    Protein Sci; 1997 Sep; 6(9):2007-15. PubMed ID: 9300500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-bromoacetyl-D-leucylglycine. An affinity label for neutral endopeptidase 24.11.
    Bateman RC; Kim YA; Slaughter C; Hersh LB
    J Biol Chem; 1990 May; 265(15):8365-8. PubMed ID: 2341387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for PQQ as cofactor in 3,4-dihydroxyphenylalanine (dopa) decarboxylase of pig kidney.
    Groen BW; van der Meer RA; Duine JA
    FEBS Lett; 1988 Sep; 237(1-2):98-102. PubMed ID: 2844591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cloning and expression of pig kidney dopa decarboxylase: comparison of the naturally occurring and recombinant enzymes.
    Moore PS; Dominici P; Borri Voltattorni C
    Biochem J; 1996 Apr; 315 ( Pt 1)(Pt 1):249-56. PubMed ID: 8670114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The reaction of pyridoxal phosphate with holoenzymes in the pyridoxamine phosphate form.
    Minelli A; Borri Voltattorni C; Grant P; Basford JM; John RA
    Prog Clin Biol Res; 1984; 144A():289-94. PubMed ID: 6374674
    [No Abstract]   [Full Text] [Related]  

  • 14. Stereospecificity of sodium borohydride reduction of pig kidney dopa decarboxylase.
    Dominici P; Tancini B; Voltattorni CB
    Arch Biochem Biophys; 1986 Dec; 251(2):762-6. PubMed ID: 3099646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Irreversible inactivation of aspartate aminotransferase by 2-oxoglutaconic acid and its dimethyl ester.
    Kato Y; Asano Y; Makar TK; Cooper AJ
    J Biochem; 1996 Sep; 120(3):531-9. PubMed ID: 8902617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Green tea polyphenols: novel irreversible inhibitors of dopa decarboxylase.
    Bertoldi M; Gonsalvi M; Voltattorni CB
    Biochem Biophys Res Commun; 2001 Jun; 284(1):90-3. PubMed ID: 11374875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reaction specificity of native and nicked 3,4-dihydroxyphenylalanine decarboxylase.
    Bertoldi M; Frigeri P; Paci M; Voltattorni CB
    J Biol Chem; 1999 Feb; 274(9):5514-21. PubMed ID: 10026165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purification and characterization of rat-liver 3,4-dihydroxyphenylalanine decarboxylase.
    Dominici P; Tancini B; Barra D; Voltattorni CB
    Eur J Biochem; 1987 Nov; 169(1):209-13. PubMed ID: 3119338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific labeling of the active site of cytosolic aspartate aminotransferase through the use of a cofactor analogue, N-(Bromoacetyl)pyridoxamine.
    Farach HA; Mattingly JR; Martinez-Carrion M
    Biochemistry; 1983 Mar; 22(5):1034-9. PubMed ID: 6838838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pig kidney dopa decarboxylase. Structure and function.
    Dominici P; Filipponi P; SchininĂ  ME; Barra D; Borri Voltattorni C
    Ann N Y Acad Sci; 1990; 585():162-72. PubMed ID: 2162642
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.